$TELA
TELA Bio, Inc.

2022 Q4 Form 10-Q Financial Statement

#000155837022017464 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $11.62M $11.16M $7.654M
YoY Change 38.79% 45.79% 44.06%
Cost Of Revenue $3.446M $3.840M $3.052M
YoY Change 26.92% 25.82% 50.34%
Gross Profit $8.176M $7.319M $4.602M
YoY Change 44.48% 59.04% 40.01%
Gross Profit Margin 70.35% 65.59% 60.13%
Selling, General & Admin $14.89M $14.70M $10.41M
YoY Change 28.49% 41.25% 16.33%
% of Gross Profit 182.11% 200.9% 226.21%
Research & Development $2.726M $2.102M $1.409M
YoY Change 58.03% 49.18% 17.32%
% of Gross Profit 33.34% 28.72% 30.62%
Depreciation & Amortization $207.0K $205.0K $127.0K
YoY Change 51.09% 61.42% -9.29%
% of Gross Profit 2.53% 2.8% 2.76%
Operating Expenses $17.62M $16.81M $11.82M
YoY Change 32.31% 42.19% 16.44%
Operating Profit -$9.439M -$9.487M -$7.217M
YoY Change 23.32% 31.45% 5.16%
Interest Expense -$1.174M $1.032M $922.0K
YoY Change 27.33% 11.93% 2.67%
% of Operating Profit
Other Income/Expense, Net $634.0K -$1.227M -$1.049M
YoY Change -1574.42% 16.97% 24.88%
Pretax Income -$9.979M -$10.71M -$8.266M
YoY Change 15.78% 29.62% 7.35%
Income Tax
% Of Pretax Income
Net Earnings -$9.979M -$10.71M -$8.266M
YoY Change 15.78% 29.62% 7.31%
Net Earnings / Revenue -85.86% -96.01% -108.0%
Basic Earnings Per Share -$0.64 -$0.57
Diluted Earnings Per Share -$0.52 -$0.64 -$570.6K
COMMON SHARES
Basic Shares Outstanding 19.16M 14.56M 14.47M
Diluted Shares Outstanding 16.76M 14.49M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $42.02M $54.23M $53.64M
YoY Change -4.35% 1.1% -34.16%
Cash & Equivalents $42.02M $54.23M $53.64M
Short-Term Investments
Other Short-Term Assets $2.015M $1.903M $2.061M
YoY Change -37.65% -7.67% 136.9%
Inventory $11.79M $12.14M $6.269M
Prepaid Expenses
Receivables $6.621M $5.688M $3.573M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $62.45M $73.96M $65.54M
YoY Change 5.74% 12.84% -26.38%
LONG-TERM ASSETS
Property, Plant & Equipment $1.682M $1.748M $891.0K
YoY Change 41.82% 96.18% 37.08%
Goodwill
YoY Change
Intangibles $2.499M $2.594M $2.379M
YoY Change 8.51% 9.04%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.408M $5.608M $3.270M
YoY Change 55.0% 71.5% -1.8%
TOTAL ASSETS
Total Short-Term Assets $62.45M $73.96M $65.54M
Total Long-Term Assets $5.408M $5.608M $3.270M
Total Assets $67.86M $79.56M $68.81M
YoY Change 8.49% 15.63% -25.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.534M $4.856M $2.334M
YoY Change -36.45% 108.05% 138.16%
Accrued Expenses $10.87M $10.36M $7.043M
YoY Change 33.18% 47.07% 61.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.40M $15.21M $9.377M
YoY Change 17.29% 62.25% 75.27%
LONG-TERM LIABILITIES
Long-Term Debt $39.92M $39.77M $31.32M
YoY Change 26.75% 26.99% 2.1%
Other Long-Term Liabilities $1.231M $1.282M $388.0K
YoY Change 223.95% 230.41%
Total Long-Term Liabilities $41.15M $41.05M $388.0K
YoY Change 10728.16% 10479.38% -98.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.40M $15.21M $9.377M
Total Long-Term Liabilities $41.15M $41.05M $388.0K
Total Liabilities $53.55M $56.26M $41.08M
YoY Change 26.16% 36.96% 14.05%
SHAREHOLDERS EQUITY
Retained Earnings -$274.2M -$264.2M -$221.3M
YoY Change 19.25% 19.38%
Common Stock $19.00K $19.00K $15.00K
YoY Change 26.67% 26.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.31M $23.30M $27.73M
YoY Change
Total Liabilities & Shareholders Equity $67.86M $79.56M $68.81M
YoY Change 8.49% 15.63% -25.49%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$9.979M -$10.71M -$8.266M
YoY Change 15.78% 29.62% 7.31%
Depreciation, Depletion And Amortization $207.0K $205.0K $127.0K
YoY Change 51.09% 61.42% -9.29%
Cash From Operating Activities -$10.98M -$7.649M -$6.630M
YoY Change 14.55% 15.37% 79.67%
INVESTING ACTIVITIES
Capital Expenditures $1.046M -$290.0K -$291.0K
YoY Change -461.94% -0.34% 870.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$1.046M -$290.0K -$291.0K
YoY Change 261.94% -0.34% 870.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -219.0K 34.57M 259.0K
YoY Change -225.86% 13247.1% -192.5%
NET CHANGE
Cash From Operating Activities -10.98M -7.649M -6.630M
Cash From Investing Activities -1.046M -290.0K -291.0K
Cash From Financing Activities -219.0K 34.57M 259.0K
Net Change In Cash -12.25M 26.63M -6.662M
YoY Change 26.23% -499.73% 66.55%
FREE CASH FLOW
Cash From Operating Activities -$10.98M -$7.649M -$6.630M
Capital Expenditures $1.046M -$290.0K -$291.0K
Free Cash Flow -$12.03M -$7.359M -$6.339M
YoY Change 29.36% 16.09% 73.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.24
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.71
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16758573
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14485688
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15293094
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14461174
dei Entity Central Index Key
EntityCentralIndexKey
0001561921
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
us-gaap Net Income Loss
NetIncomeLoss
-34317000
us-gaap Net Income Loss
NetIncomeLoss
-24657000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1200000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39130
dei Entity Registrant Name
EntityRegistrantName
TELA Bio, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-5320061
dei Entity Address Address Line1
EntityAddressAddressLine1
1 Great Valley Parkway, Suite 24
dei Entity Address City Or Town
EntityAddressCityOrTown
Malvern
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19355
dei City Area Code
CityAreaCode
484
dei Local Phone Number
LocalPhoneNumber
320-2930
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
TELA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19159145
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54226000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43931000
CY2022Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
5688000
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4234000
CY2022Q3 us-gaap Inventory Net
InventoryNet
12138000
CY2021Q4 us-gaap Inventory Net
InventoryNet
7658000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1903000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3232000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
73955000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
59055000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1748000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1186000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2594000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2303000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1266000
CY2022Q3 us-gaap Assets
Assets
79563000
CY2021Q4 us-gaap Assets
Assets
62544000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4856000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2414000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10358000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8161000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15214000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10575000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39766000
CY2021Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
31491000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1282000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
380000
CY2022Q3 us-gaap Liabilities
Liabilities
56262000
CY2021Q4 us-gaap Liabilities
Liabilities
42446000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19159145
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14529606
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19159145
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14529577
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
19000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
287266000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
250064000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
262000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-264246000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-229929000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
23301000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20098000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79563000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62544000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11159000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7654000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29796000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21089000
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
3745000
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2976000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
10219000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
7707000
CY2022Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
95000
CY2021Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
76000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
709000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
228000
CY2022Q3 us-gaap Gross Profit
GrossProfit
7319000
CY2021Q3 us-gaap Gross Profit
GrossProfit
4602000
us-gaap Gross Profit
GrossProfit
18868000
us-gaap Gross Profit
GrossProfit
13154000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11172000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6948000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
31605000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20749000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3532000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3462000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10620000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9184000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2102000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1409000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6211000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5018000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
16806000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
11819000
us-gaap Operating Expenses
OperatingExpenses
48436000
us-gaap Operating Expenses
OperatingExpenses
34951000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9487000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7217000
us-gaap Operating Income Loss
OperatingIncomeLoss
-29568000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21797000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1032000
CY2021Q3 us-gaap Interest Expense
InterestExpense
922000
us-gaap Interest Expense
InterestExpense
2877000
us-gaap Interest Expense
InterestExpense
2675000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1228000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-195000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-127000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-644000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-185000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1227000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1049000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4749000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2860000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10714000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8266000
us-gaap Net Income Loss
NetIncomeLoss
-34317000
us-gaap Net Income Loss
NetIncomeLoss
-24657000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.71
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16758573
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14485688
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15293094
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14461174
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10714000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8266000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
133000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
38000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
314000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
28000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10581000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8228000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34003000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24629000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1542000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
133000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1027000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34400000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10714000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
23301000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20098000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
157000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
314000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2950000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
34400000
us-gaap Net Income Loss
NetIncomeLoss
-34317000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
23301000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
34965000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
259000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
38000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
733000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-8266000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
27729000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
49026000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
411000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
28000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2839000
tela Adjustments To Additional Paid In Capital Reclassification Of Liability Classified Stock Based Compensation
AdjustmentsToAdditionalPaidInCapitalReclassificationOfLiabilityClassifiedStockBasedCompensation
82000
us-gaap Net Income Loss
NetIncomeLoss
-24657000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
27729000
us-gaap Net Income Loss
NetIncomeLoss
-34317000
us-gaap Net Income Loss
NetIncomeLoss
-24657000
us-gaap Depreciation
Depreciation
271000
us-gaap Depreciation
Depreciation
170000
us-gaap Paid In Kind Interest
PaidInKindInterest
507000
us-gaap Paid In Kind Interest
PaidInKindInterest
488000
tela Noncash Loss On Extinguishment Of Debt
NoncashLossOnExtinguishmentOfDebt
1228000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
709000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
228000
tela Net Changes In Operating Lease Right Of Use Assets And Liabilities
NetChangesInOperatingLeaseRightOfUseAssetsAndLiabilities
26000
us-gaap Inventory Write Down
InventoryWriteDown
1809000
us-gaap Inventory Write Down
InventoryWriteDown
1334000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
338000
us-gaap Share Based Compensation
ShareBasedCompensation
2950000
us-gaap Share Based Compensation
ShareBasedCompensation
2839000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1531000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
896000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6540000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3701000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1322000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-180000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2291000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1586000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
799000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1561000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-763000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-24000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-29765000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20844000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
826000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-826000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-338000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34675000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
40000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
30000000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3460000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
411000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
157000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41071000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
411000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-185000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10295000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20758000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43931000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
74394000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54226000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53636000
us-gaap Interest Paid Net
InterestPaidNet
2370000
us-gaap Interest Paid Net
InterestPaidNet
2187000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
97000
tela Offering Costs In Accounts Payable And Accrued Expense And Other Current Liabilities
OfferingCostsInAccountsPayableAndAccruedExpenseAndOtherCurrentLiabilities
275000
tela Reclassification Of Liability Classified Stock Based Compensation To Equity Classified
ReclassificationOfLiabilityClassifiedStockBasedCompensationToEquityClassified
82000
tela Accrued Milestone Payment Current
AccruedMilestonePaymentCurrent
1000000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1376000
tela Tenant Improvements And Deferred Rent Exchanged For Operating Lease Liabilities
TenantImprovementsAndDeferredRentExchangedForOperatingLeaseLiabilities
380000
tela Operating Lease Obligation Assumed
OperatingLeaseObligationAssumed
-1756000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-264200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant judgments are employed in estimates used to determine the fair value of stock-based awards issued and recoverability of the carrying value of the Company’s inventory. As future events and their effects cannot be determined with precision, actual results may differ significantly from these estimates.</p>
tela Incremental Costs Of Obtaining Contract
IncrementalCostsOfObtainingContract
0
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11159000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7654000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29796000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21089000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2404467
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1961135
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2204
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.08
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
100000
us-gaap Operating Lease Cost
OperatingLeaseCost
200000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
100000
us-gaap Operating Lease Payments
OperatingLeasePayments
300000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
88000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
358000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
366000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
375000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
383000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
392000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
165000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2127000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
507000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1620000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
300000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
400000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
400000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
400000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
400000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
500000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
300000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1300000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
75376
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.30
CY2022Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
5126000
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
4976000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2431000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2233000
CY2022Q3 tela Accrued Expenses Amount Due To Contract Manufacturer
AccruedExpensesAmountDueToContractManufacturer
2248000
CY2021Q4 tela Accrued Expenses Amount Due To Contract Manufacturer
AccruedExpensesAmountDueToContractManufacturer
842000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
338000
CY2022Q3 tela Research And Development Expenses Payable Current
ResearchAndDevelopmentExpensesPayableCurrent
90000
CY2021Q4 tela Research And Development Expenses Payable Current
ResearchAndDevelopmentExpensesPayableCurrent
31000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
125000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
79000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10358000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8161000
CY2022Q3 tela Accrued Milestone Payments Current
AccruedMilestonePaymentsCurrent
1000000.0
CY2022Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
2000000
CY2021Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
3000000
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2234000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1509000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
380360
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.44
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
39766000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
31491000
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
88556
CY2022Q3 tela Equity Incentive Plans Number
EquityIncentivePlansNumber
2
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1027000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
733000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2950000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2839000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1706409
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.88
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2009189
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M25D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1956285
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.55
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M7D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1167504
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.99
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M25D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1200000
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
29
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
29
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.689
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0228
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M8D

Files In Submission

Name View Source Status
0001558370-22-017464-index-headers.html Edgar Link pending
0001558370-22-017464-index.html Edgar Link pending
0001558370-22-017464.txt Edgar Link pending
0001558370-22-017464-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tela-20220930.xsd Edgar Link pending
tela-20220930x10q.htm Edgar Link pending
tela-20220930xex31d1.htm Edgar Link pending
tela-20220930xex31d2.htm Edgar Link pending
tela-20220930xex32d1.htm Edgar Link pending
tela-20220930xex32d2.htm Edgar Link pending
tela-20220930x10q_htm.xml Edgar Link completed
tela-20220930_lab.xml Edgar Link unprocessable
tela-20220930_cal.xml Edgar Link unprocessable
tela-20220930_def.xml Edgar Link unprocessable
tela-20220930_pre.xml Edgar Link unprocessable